Tana C, Donatiello I, Caputo A et al Clinical features, histopathology and differential diagnosis of Sarcoidosis. Cells 2021;11.

Birnie DH, Kandolin R, Nery PB, Kupari M (2017) cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 38:2663–2670

CAS  PubMed  Google Scholar 

Gilotra N, Okada D, Sharma A, Chrispin J (2020) Management of cardiac sarcoidosis in 2020. Arrhythm Electrophysiol Rev 9:182–188

Article  PubMed  PubMed Central  Google Scholar 

Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R (2016) Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 6:50–63

PubMed  PubMed Central  Google Scholar 

Aitken M, Chan MV, Urzua Fresno C et al (2022) Diagnostic accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: a systematic review and Meta-analysis. Radiology 304:566–579

Article  PubMed  Google Scholar 

Hulten E, Agarwal V, Cahill M et al (2016) Presence of Late Gadolinium Enhancement by Cardiac magnetic resonance among patients with suspected Cardiac Sarcoidosis is Associated with adverse Cardiovascular prognosis: a systematic review and Meta-analysis. Circ Cardiovasc Imaging 9:e005001

Article  PubMed  PubMed Central  Google Scholar 

Coleman GC, Shaw PW et al (2017) Prognostic value of myocardial scarring on CMR in patients with Cardiac Sarcoidosis. JACC Cardiovasc Imaging 10(4):411–420

Article  PubMed  Google Scholar 

Aitken M, Davidson M, Chan MV et al (2023) Prognostic value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: a systematic review and Meta-analysis. Radiology 307:e222483

Article  PubMed  Google Scholar 

Pontone G, Guaricci AI, Andreini D et al Prognostic Benefit of Cardiac magnetic resonance over Transthoracic Echocardiography for the Assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary Prevention Implantable cardioverter-defibrillator therapy. Circ Cardiovasc Imaging 2016;9.

Stevenson A, Bray JJH, Tregidgo L et al (2023) Prognostic value of late Gadolinium Enhancement detected on Cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging 16:345–357

Article  PubMed  Google Scholar 

Wang J, Zhang J, Hosadurg N et al (2023) Prognostic value of RV abnormalities on CMR in patients with known or suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging 16:361–372

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Article  PubMed  PubMed Central  Google Scholar 

Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323

Article  PubMed  Google Scholar 

Sugisaki K (2008) [Diagnostic guidelines and Criteria for Sarcoidosis–2006]. Nihon Kokyuki Gakkai Zasshi 46:768–780

CAS  PubMed  Google Scholar 

Fumio Terasaki A, Azuma T, Anzai et al (2019) JCS 2016 Guideline on diagnosis and treatment of Cardiac Sarcoidosis. Circ J 83:2329–2388

Article  PubMed  Google Scholar 

Deeks JJ, Dinnes J, D’Amico R et al (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7:iii–x

Article  CAS  PubMed  Google Scholar 

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

Article  PubMed  Google Scholar 

Jin ZC, Zhou XH, He J (2015) Statistical methods for dealing with publication bias in meta-analysis. Stat Med 34:343–360

Article  PubMed  Google Scholar 

Agoston-Coldea L, Kouaho S, Sacre K et al (2016) High mass (> 18 g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Int J Cardiol 222:950–956

Article  PubMed  Google Scholar 

Athwal PSS, Chhikara S, Ismail MF et al (2022) Cardiovascular Magnetic Resonance Imaging Phenotypes and long-term outcomes in patients with suspected Cardiac Sarcoidosis. Jama Cardiol 7:1057–1066

Article  PubMed  PubMed Central  Google Scholar 

Bravo PE, Raghu G, Rosenthal DG et al (2017) Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. Int J Cardiol 241:457–462

Article  PubMed  PubMed Central  Google Scholar 

Crawford T, Mueller G, Sarsam S et al (2014) Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol 7:1109–1115

Article  PubMed  Google Scholar 

Ekström K, Lehtonen J, Hänninen H, Kandolin R, Kivistö S, Kupari M (2016) Magnetic Resonance Imaging as a predictor of Survival Free of Life-threatening arrhythmias and transplantation in Cardiac Sarcoidosis. J Am Heart Assoc ;5

Flamee L, Symons R, Degtiarova G et al (2020) Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Eur Radiol 30:3702–3710

Article  PubMed  Google Scholar 

Gowani Z, Habibi M, Okada DR et al (2020) Utility of Cardiac magnetic resonance imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for ventricular arrhythmias in patients with Cardiac Sarcoidosis. Am J Cardiol 134:123–129

Article  PubMed  Google Scholar 

Greulich S, Deluigi CC, Gloekler S et al (2013) CMR Imaging predicts death and other adverse events in suspected Cardiac Sarcoidosis. Jacc-Cardiovascular Imaging 6:501–511

Article  PubMed  Google Scholar 

Ise T, Hasegawa T, Morita Y et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100:1165–1172

Article  CAS  PubMed  Google Scholar 

Kagioka Y, Yasuda M, Okune M et al (2020) Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging. Clin Res Cardiol 109:988–998

Article  CAS  PubMed  Google Scholar 

Kouranos V, Tzelepis GE, Rapti A et al (2017) Complementary role of CMR to conventional screening in the diagnosis and prognosis of Cardiac Sarcoidosis. Jacc-Cardiovascular Imaging 10:1437–1447

Article  PubMed  Google Scholar 

Matsumoto K, Ehara S, Sakaguchi M et al (2015) Clinical characteristics of late Gadolinium Enhancement in patients with Cardiac Sarcoidosis. Osaka City Med J 61:9–17

CAS  PubMed  Google Scholar 

Murtagh G, Laffin LJ, Beshai JF et al (2016) Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection Fraction Risk Stratification using Cardiovascular magnetic resonance. Circulation-Cardiovascular Imaging ;9

Nadel J, Lancefield T, Voskoboinik A, Taylor AJ (2015) Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart Journal-Cardiovascular Imaging 16:634–641

Google Scholar 

Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K (2014) Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without Cardiac Manifestation. Chest 146:1064–1072

Article  CAS  PubMed  Google Scholar 

Okada DR, Xie E, Assis F et al (2019) Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 30:1967–1976

Article  PubMed  Google Scholar 

Patel MR, Cawley PJ, Heitner JF et al (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120:1969–1977

Article  PubMed  PubMed Central  Google Scholar 

Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns H (2018) Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail 5:157–171

Article  PubMed  Google Scholar 

Velangi PS, Chen KA, Kazmirczak F et al (2020) Right ventricular abnormalities on Cardiovascular Magnetic Resonance Imaging in patients with sarcoidosis. JACC Cardiovasc Imaging 13:1395–1405

Article  PubMed  PubMed Central